Beacon Therapeutics may have found a guiding light in a disease area where other companies have stumbled with its laruparetigene zovaparvovec (laru-zova), a gene therapy that proved early improvements ...
Genetic diseases are a compelling target for viral gene therapy, but the results can be spotty at best. There's good news, though. On Wednesday, researchers presented evidence from a breakthrough gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results